Use of Prineo in Breast Reduction Surgery
Prineo
Use of Prineo™ for Wound Closure in Breast Reduction Surgery
1 other identifier
interventional
21
1 country
1
Brief Summary
This is a prospective, randomized, controlled, single-blinded study to compare Prineo™ with subcuticular sutures in 20 women undergoing bilateral breast reduction. For each patient, the final skin layer of one breast will be closed with subcuticular suture while the other breast will be closed with Prineo™. The treatment will be randomized to left or right breast. Therefore, the investigators will have 20 breasts in the suture group and 20 in the Prineo™ group, with each patient serving as her own control. For this study, the resident will close one side with suture and Dr. Rohde will apply the Prineo. The investigators will perform this study of incision closure under conditions as similar to normal conditions of closure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2014
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 22, 2013
CompletedFirst Posted
Study publicly available on registry
November 27, 2013
CompletedStudy Start
First participant enrolled
August 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2016
CompletedResults Posted
Study results publicly available
May 7, 2019
CompletedMay 7, 2019
April 1, 2019
2.3 years
November 22, 2013
March 22, 2019
April 18, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Operative Time to Closure of Final Skin Layer
This outcome measure looks at the operative time in seconds to closure of the final skin layer using Prineo or standard sutures.
During operation only
Secondary Outcomes (1)
Score on Patient Observer Scar Assessment Scale (POSAS)
Up to 1 year
Other Outcomes (1)
Score on the Vancouver Scar Scale (VSS)
Up to 1 year
Study Arms (2)
Prineo closure
ACTIVE COMPARATOROne breast will have skin closure with Prineo.
Standard Suture
NO INTERVENTIONOne breast will be closed in the standard fashion with suture.
Interventions
After a Wise pattern breast reduction, one breast will have final layer closure with Prineo, while the other breast will be closed in the standard fashion with sutures.
Eligibility Criteria
You may qualify if:
- Women undergoing Wise pattern breast reductions for symptomatic macromastia.
You may not qualify if:
- Subjects who have an allergy to cyanoacrylate, formaldehyde, surgical tape, or any other known component of the Prineo system will be excluded.
- Subjects who refuse to be photographed or refuse to have their scars assessed by a blinded plastic surgeon will be excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Columbia Universitylead
- Ethicon, Inc.collaborator
Study Sites (1)
Columbia University Medical Center
New York, New York, 10021, United States
Related Publications (3)
Draaijers LJ, Tempelman FR, Botman YA, Tuinebreijer WE, Middelkoop E, Kreis RW, van Zuijlen PP. The patient and observer scar assessment scale: a reliable and feasible tool for scar evaluation. Plast Reconstr Surg. 2004 Jun;113(7):1960-5; discussion 1966-7. doi: 10.1097/01.prs.0000122207.28773.56.
PMID: 15253184BACKGROUNDvan de Kar AL, Corion LU, Smeulders MJ, Draaijers LJ, van der Horst CM, van Zuijlen PP. Reliable and feasible evaluation of linear scars by the Patient and Observer Scar Assessment Scale. Plast Reconstr Surg. 2005 Aug;116(2):514-22. doi: 10.1097/01.prs.0000172982.43599.d6.
PMID: 16079683BACKGROUNDDunst KM, Auboeck J, Zahel B, Raffier B, Huemer GM. Extensive allergic reaction to a new wound closure device (Prineo). Allergy. 2010 Jun 1;65(6):798-9. doi: 10.1111/j.1398-9995.2009.02243.x. Epub 2009 Nov 11. No abstract available.
PMID: 19909297BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Christine Rohde, MD
- Organization
- Columbia University
Study Officials
- PRINCIPAL INVESTIGATOR
Christine Rohde, MD,MPH
Columbia University
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Surgery
Study Record Dates
First Submitted
November 22, 2013
First Posted
November 27, 2013
Study Start
August 1, 2014
Primary Completion
December 1, 2016
Study Completion
December 1, 2016
Last Updated
May 7, 2019
Results First Posted
May 7, 2019
Record last verified: 2019-04